| Literature DB >> 10565524 |
Abstract
Treatment of glaucoma continues to be directed at lowering intraocular pressure to decrease the likelihood of disease progression. In the future intraocular pressure reduction might be augmented by other therapeutic approaches. Interest has been increasing in preventing progression of glaucomatous optic neuropathy using approaches based on the premise that glaucoma is a neurodegenerative disease. Neuroprotection of the glaucomatous optic nerve therefore would be an adjuctive therapeutic paradigm for use with conventional intraocular pressure-lowering treatments or by itself.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10565524 DOI: 10.1001/archopht.117.11.1540
Source DB: PubMed Journal: Arch Ophthalmol ISSN: 0003-9950